HAYWARD, Calif., January 7, 2009 – IMPAX Laboratories, Inc. today announced that it will present at the 27th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th, at 4:00 p.m. Pacific time. The conference will be held at the Westin St. Francis Hotel, San Francisco from January 12 to 15, 2009.
Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company’s web site at www.impaxlabs.com . This presentation will be archived on the Company’s web site for 30 days.
About IMPAX Laboratories, Inc.
IMPAX Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. IMPAX markets its generic products through its Global Pharmaceuticals division and markets its branded products through the IMPAX Pharmaceuticals division. Additionally, where strategically appropriate, IMPAX has developed marketing partnerships to fully leverage its technology platform. IMPAX Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia facilities. For more information, please visit the Company's Web site at: www.impaxlabs.com.
Company Contacts:
IMPAX Laboratories, Inc.
Larry Hsu, Ph.D. President & CEO
(510) 476-2000, Ext. 1111
Arthur A. Koch, Jr., Sr. VP & CFO
(215) 933-0351
Mark Donohue, Sr. Director Investor Relations
(215) 933-3526
www.impaxlabs.com